NEW! DEA MATE ACT:
Beginning with DEA initial registrations or renewals starting June 27, 2023, all DEA-registered practitioners (with the exception of DVM-only license holders) are required to complete 8 hours of one-time training on the treatment and management of patients with opioid or other substance use disorders.

Mandatory Subjects:
Two (2) AMA PRA Category 1 Credits™ or equivalent every two years in the areas of:
 

• Controlled substance prescribing practices,
• Recognizing signs of the abuse or misuse of controlled substances, or
• Controlled substance prescribing for chronic pain management.
• Any program in these areas is acceptable to meet the CME credits required of all ACSC holders every two years. You do not need to obtain pre-approval of the courses you choose.

NEW! DEA MATE ACT:
Beginning with DEA initial registrations or renewals starting June 27, 2023, all DEA-registered practitioners (with the exception of DVM-only license holders) are required to complete 8 hours of one-time training on the treatment and management of patients with opioid or other substance use disorders.

Mandatory Subjects: 
If you hold a valid DEA registration, at least two of the total hours of CME that are required to qualify for renewal must be specific to pain management and opioid use and addiction.

NEW! DEA MATE ACT:
Beginning with DEA initial registrations or renewals starting June 27, 2023, all DEA-registered practitioners (with the exception of DVM-only license holders) are required to complete 8 hours of one-time training on the treatment and management of patients with opioid or other substance use disorders.

Mandatory Subjects:
Licensees who hold a Qualified Alabama Controlled Substances Certificate (QACSC) are required 4 hours of AMA PRA Category 1 Credit™ in advanced pharmacology and prescribing trends relating to controlled substances every two years.